Kennard, L. E., Chumbley, J. R., Ranatunga, K. M., Armstrong, S. J., Veale, E. L., & Mathie, A. (2005). Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine.

Kennard, Louise E., Justin R. Chumbley, Kishani M. Ranatunga, Stephanie J. Armstrong, Emma L. Veale, a Alistair Mathie. Inhibition of the Human Two-pore Domain Potassium Channel, TREK-1, By Fluoxetine and Its Metabolite Norfluoxetine. 2005.

Kennard, Louise E., et al. Inhibition of the Human Two-pore Domain Potassium Channel, TREK-1, By Fluoxetine and Its Metabolite Norfluoxetine. 2005.